US 9187497
Substituted pyrido[3,2-e]pyrrolo[1,2-a]pyrazines as inhibitors of poly(ADP-ribose)polymerase (PARP)
granted A61KA61K31/4985A61K31/506
Quick answer
US patent 9187497 (Substituted pyrido[3,2-e]pyrrolo[1,2-a]pyrazines as inhibitors of poly(ADP-ribose)polymerase (PARP)) held by Takeda Pharmaceutical Company Limited expires Mon Nov 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Nov 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/4985, A61K31/506, A61K31/53, A61K31/5383